SARAH BARDIN: Open Payments
NPI 1477116036 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 33 payments from 8 companies in 2025. Trend: 2023 $719 · 2024 $614 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $154 |
| Novartis Pharmaceuticals Corporation | 6 | $114 |
| Kestra Medical Technology Services, Inc. | 4 | $110 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $70 |
| Novo Nordisk Inc | 4 | $66 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Amgen Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: LEQVIO, Assure WCD, CAMZYOS, LifeVest, Wegovy, ELIQUIS, VERQUVO, REPATHA.
Industry payments across LA — which companies pay providers there.
